Liu H, Sridhar VS, Boulet J et al (2022) Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
CVS Caremark selected Wegovy as its preferred GLP-1 for weight loss effective July 1, 2025, removing Zepbound from these formulary types: [2] Standard Control Formulary Most common employer formulary Advanced Control Formulary More restrictive formulary with lower premiums Value Formulary Cost-focused formulary used by smaller employers Background: The Zepbound Class Action Lawsuits In September 2025, two class action lawsuits were filed by Zepbound patients against CVS Caremark: [3][8] (Sept
Conclusion Navigating the side effects of a weight loss medication can feel overwhelming, but you dont have to do it alone
The robotic pill theyve created is called VIBES (for vibrating ingestible bioelectronic stimulator)
Whenever starting a new medication, always consult with a reputable board-certified doctor
Many of these conditions have resulted in hospitalization and even death